Medicare Enrolled
Dr. Jennifer Barbieri, MD
Pulmonary Disease · Rome, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barbieri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barbieri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barbieri
Dr. Jennifer Barbieri is a pulmonary disease specialist in Rome, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barbieri performed 1,780 Medicare services across 1,202 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barbieri received a total of $10,086 from 53 pharmaceutical and/or device companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barbieri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 22% volume in GA
$10,086 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,780
Medicare services
Top 22% in GA for pulmonary disease
1,202
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~89 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
511 | $84 | $158 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
279 | $160 | $443 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
192 | $88 | $167 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
127 | $18 | $104 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
93 | $37 | $119 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
93 | $37 | $109 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
86 | $54 | $502 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
82 | $130 | $303 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
67 | $15 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $58 | $107 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
45 | $23 | $155 |
| New patient office visit, complex (60-74 min) | 40 | $158 | $303 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
37 | $8 | $15 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
29 | $92 | $670 |
| Drainage of fluid from chest cavity with insertion of indwelling tube | 19 | $95 | $1,640 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
17 | $29 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
14 | $72 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,086
Total received (2018-2024)
Avg $1,441/year across 7 years
Top 21% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
564
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,086 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,221
2023
$1,487
2022
$1,105
2021
$1,021
2020
$1,416
2019
$2,224
2018
$1,611
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$141
AstraZeneca Pharmaceuticals LP
$140
ANI Pharmaceuticals, Inc.
$112
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
United Therapeutics Corporation
$94
Amgen Inc.
$78
GENZYME CORPORATION
$72
HARMONY BIOSCIENCES LLC
$67
Grifols USA, LLC
$62
Insmed, Inc.
$57
Axsome Therapeutics, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$46
Resmed Corp
$35
Mylan Specialty L.P.
$28
Mallinckrodt Hospital Products Inc.
$25
Actelion Pharmaceuticals US, Inc.
$22
Vifor Pharma, Inc.
$21
ABBVIE INC.
$14
Top 3 companies account for 32.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,947
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,376
AstraZeneca Pharmaceuticals LP
$658
Actelion Pharmaceuticals US, Inc.
$644
Grifols USA, LLC
$514
Mylan Specialty L.P.
$513
United Therapeutics Corporation
$465
Sunovion Pharmaceuticals Inc.
$419
GENZYME CORPORATION
$407
Teva Pharmaceuticals USA, Inc.
$256
Insmed, Inc.
$250
Regeneron Healthcare Solutions, Inc.
$230
Philips Electronics North America Corporation
$196
Novartis Pharmaceuticals Corporation
$189
ANI Pharmaceuticals, Inc.
$176
Mallinckrodt Hospital Products Inc.
$170
Genentech USA, Inc.
$148
Amgen Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$110
Circassia Pharmaceuticals Inc
$97
PFIZER INC.
$90
Advanced Respiratory, Inc
$86
Gilead Sciences, Inc.
$77
HARMONY BIOSCIENCES LLC
$67
Electromed, Inc.
$66
Merck Sharp & Dohme Corporation
$58
Axsome Therapeutics, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$51
Bayer HealthCare Pharmaceuticals Inc.
$49
Harmony Biosciences LLC
$46
JAZZ PHARMACEUTICALS INC.
$42
La Jolla Pharmaceutical Company
$41
Allergan, Inc.
$41
Shire North American Group Inc
$36
Resmed Corp
$35
Eisai Inc.
$34
AbbVie Inc.
$28
ABBVIE INC.
$26
Allergan Inc.
$25
Mallinckrodt Enterprises LLC
$22
SANOFI-AVENTIS U.S. LLC
$22
Vifor Pharma, Inc.
$21
Mallinckrodt LLC
$20
Inspire Medical Systems, Inc.
$19
Merck Sharp & Dohme LLC
$19
Tactile Systems Technology Inc
$18
Covis Pharma GmBH
$17
Inogen, Inc.
$17
CHIESI USA, INC.
$17
Janssen Pharmaceuticals, Inc
$15
Alexion Pharmaceuticals, Inc.
$14
Jazz Pharmaceuticals Inc.
$12
PORTOLA PHARMACEUTICALS, INC.
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · CLEVIPREX · DS Cpap Auto Core · DUPIXENT · Dayvigo · Dymista · Esbriet · FASENRA · Flexitouch Plus · GIAPREZA · GLASSIA · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Resp Care Undiv · Respiratoriy Care Undiv · SEEBRI · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The VisiVest Airway Clearance System · UPTRAVI · UTIBRON NEOHALER · Ultomiris · Utibron · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · Xembify · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
5
Per 100K population
5.1
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barbieri is a clinical cardiology specialist, with above-average Medicare volume (top 22% in GA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barbieri experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Barbieri performed 511 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barbieri receive payments from pharmaceutical companies?
Yes. Dr. Barbieri received a total of $10,086 from 53 companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barbieri's costs compare to other pulmonary diseases in Rome?
Dr. Barbieri's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barbieri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Rome
Browse pulmonary diseases in Rome ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology